About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...

Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of ...

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

The Desert Hot Springs Police Department will conduct a DUI checkpoint later this week at an undisclosed location within the ...

Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the ...

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...

Analysts are intrested in these 5 stocks: ( ($BEAM) ), ( ($U) ), ( ($CKPT) ), ( ($INUV) ) and ( ($OCUL) ). Here is a ...

Elk Grove Police to conduct a DUI and Driver's License Checkpoint on Friday night, aiming to prevent impaired driving and promote road safety, funded by traffic safety agencies.

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Detailed price information for Lyra Therapeutics Inc (LYRA-Q) from The Globe and Mail including charting and trades.

TG Therapeutics, Inc.’s TGTX share price has surged by 10.20%, which has investors questioning if this is right time to sell.